fotemustine
Showing 1 - 6 of 6
Malignant Melanoma, Recurrent Melanoma Trial (Dacarbazine, Fotemustine, Interferon Alfa-2b)
Completed
- Malignant Melanoma
- Recurrent Melanoma
- Dacarbazine
- +2 more
- (no location specified)
Oct 18, 2020
Malignant Melanoma Trial in Italy (bevacizumab [Avastin], fotemustine)
Completed
- Malignant Melanoma
- bevacizumab [Avastin]
- fotemustine
-
Firenze, Italy
- +3 more
Nov 7, 2018
Glioblastoma Multiforme Trial in Italy (bevacizumab [Avastin], fotemustine)
Completed
- Glioblastoma Multiforme
- bevacizumab [Avastin]
- fotemustine
-
Napoli, Campania, Italy
- +9 more
Feb 16, 2016
Brain Metastases Trial in Italy (Fotemustine, Fotemustine and Ipilimumab, Ipilimumab and nivolumab)
Unknown status
- Brain Metastases
- Fotemustine
- +2 more
-
Bari, Italy
- +10 more
Jun 1, 2015
Intraocular Melanoma, Metastatic Cancer Trial in Worldwide (fotemustine, isolated perfusion)
Terminated
- Intraocular Melanoma
- Metastatic Cancer
- fotemustine
- isolated perfusion
-
Milan, Italy
- +7 more
Sep 20, 2012
Melanoma (Skin) Trial in Montpellier (fotemustine, gene expression analysis, polymerase chain reaction)
Completed
- Melanoma (Skin)
- fotemustine
- +2 more
-
Montpellier, FranceCentre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
May 13, 2011